Phenotypic correlates of structural and functional protein impairments resultant from ALDH5A1 variants
Authors:
- Itay Tokatly LatzerILItay Tokatly Latzer
- Jean-Baptiste RoulletJRJean-Baptiste Roullet
- Samuele CesaroSCSamuele Cesaro
- Melissa L. DiBaccoMDMelissa L. DiBacco
- Erland ArningEAErland Arning
- Alexander RotenbergARAlexander Rotenberg
- Henry H. C. LeeHenry H. C. Lee
- Thomas OpladenTOThomas Opladen
- Kathrin JeltschKJKathrin Jeltsch
- Àngels García-CazorlaÀGÀngels García-Cazorla
- Natalia Juliá-PalaciosNJNatalia Juliá-Palacios
- K. Michael GibsonK. Michael Gibson
- 14 November 2023
- journal article
- research article
- Published by Springer Nature in Human Genetics
- Vol. 142 (12) , 1755-1776
Abstract
To investigate the genotype-to-protein-to-phenotype correlations of succinic semialdehyde dehydrogenase deficiency (SSADHD), an inherited metabolic disorder of γ-aminobutyric acid catabolism. Bioinformatics and in silico mutagenesis analyses of ALDH5A1 variants were performed to evaluate their impact on protein stability, active site and co-factor binding domains, splicing, and homotetramer formation. Protein abnormalities were then correlated with a validated disease-specific clinical severity score and neurological, neuropsychological, biochemical, neuroimaging, and neurophysiological metrics. A total of 58 individuals (1:1 male/female ratio) were affected by 32 ALDH5A1 pathogenic variants, eight of which were novel. Compared to individuals with single homotetrameric or multiple homo and heterotetrameric proteins, those predicted not to synthesize any functional enzyme protein had significantly lower expression of ALDH5A1 (p = 0.001), worse overall clinical outcomes (p = 0.008) and specifically more severe cognitive deficits (p = 0.01), epilepsy (p = 0.04) and psychiatric morbidity (p = 0.04). Compared to individuals with predictions of having no protein or a protein impaired in catalytic functions, subjects whose proteins were predicted to be impaired in stability, folding, or oligomerization had a better overall clinical outcome (p = 0.02) and adaptive skills (p = 0.04). The quantity and type of enzyme proteins (no protein, single homotetramers, or multiple homo and heterotetramers), as well as their structural and functional impairments (catalytic or stability, folding, or oligomerization), contribute to phenotype severity in SSADHD. These findings are valuable for assessment of disease prognosis and management, including patient selection for gene replacement therapy. Furthermore, they provide a roadmap to determine genotype-to-protein-to-phenotype relationships in other autosomal recessive disorders.Keywords
All Related Versions
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (1R01HD091142, 1R01HD091142, 1R01HD091142, 1R01HD091142, 1R01HD091142, 1R01HD091142, 1R01HD091142, 1R01HD091142, 1R01HD091142)
This publication has 40 references indexed in Scilit:
- GABA B -ergic motor cortex dysfunction in SSADH deficiencyNeurology, 2012
- Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic StrategiesEpilepsia, 2010
- Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiencyNeurology, 2009
- Redox‐switch modulation of human SSADH by dynamic catalytic loopThe EMBO Journal, 2009
- Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during developmentBMC Developmental Biology, 2008
- Cognitive Functioning and Survival in the Elderly: The SSADH C538T PolymorphismAnnals of Human Genetics, 2008
- Elliott, C. D. (2007). Differential Ability Scales (2nd ed.). San Antonio, TX: Harcourt AssessmentCanadian Journal of School Psychology, 2007
- Standard Mutation Nomenclature in Molecular DiagnosticsThe Journal of Molecular Diagnostics, 2007
- CUPSAT: prediction of protein stability upon point mutationsNucleic Acids Research, 2006
- Mutational spectrum of the succinate semialdehyde dehydrogenase (ALDH5A1) gene and functional analysis of 27 novel disease-causing mutations in patients with SSADH deficiencyHuman Mutation, 2003